Amlodipine Besylate; Telmisartan is Used for managing high blood pressure. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Twynsta on Oct 16, 2009. 5 different companies have introduced drugs containing Amlodipine Besylate; Telmisartan.

Amlodipine Besylate; Telmisartan Patents

Given below is the list of patents protecting Amlodipine Besylate; Telmisartan, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)

• Argentina (AR)
• Australia (AU)
• Brazil (BR)
• Canada (CA)
• Chile (CL)
• China (CN)
• India (IN)
• Japan (JP)
• Mexico (MX)
• Paraguay (PY)
• Philippines (PH)
• Russia (RU)
• Singapore (SG)
• South Africa (ZA)
• Thailand (TH)
• United States (US)
• Uruguay (UY)
• Eurasian Patent Organization (EA)
• World Intellectual Property Organization (WO)
• Taiwan (TW)
• European Patent Office (EP)

Patent Category : All

• All
• Combination
• Compound
• Device
• Dosage Regimen
• Formulation
• Other Forms
• Polymorph
• Process
• Use Method

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Twynsta	US5591762	Benzimidazoles useful as angiotensin-11 antagonists	Jan 07, 2014 (Expired)	Boehringer Ingelheim

Add above patents to watchlist

Amlodipine Besylate; Telmisartan's Family Patents

Unlock Global Patents

Amlodipine Besylate; Telmisartan Generic API Manufacturers

Several generic applications have been filed for Amlodipine Besylate; Telmisartan. The first generic version for Amlodipine Besylate; Telmisartan was by Lupin Ltd and was approved on Jan 8, 2014. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Nov 17, 2016.

Given below is the list of companies who have filed for Amlodipine Besylate; Telmisartan generic, along with the locations of their manufacturing plants worldwide.